Active ingredientArtesunateCat. No. P-A192-001CAS 88495-63-0Family · Pharmaceutical analytical standards
Artesunate
A semi-synthetic antimalarial derived from artemisinin, developed in 1977 by the Chinese chemist Liu Xu; the WHO recommends it as the treatment of choice for severe malaria, and it was approved in the United States in 2020. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is one of the few semi-synthetic artemisinin derivatives that dissolve in water, so it can be given intravenously; in the body it is quickly converted into its active form, dihydroartemisinin.
Go to the active ingredient →Active ingredientArtesunateCat. No. P-A192-001CAS 88495-63-0
Isotopically labelledArtesunate-d3Cat. No. P-A192-002CAS 1316303-44-2
Isotopically labelledArtesunate-d4Cat. No. P-A192-003CAS 1316753-15-7
ImpurityArtesunate Impurity 1Cat. No. P-A192-004
ImpurityArtesunate Impurity 3Cat. No. P-A192-006CAS 958447-25-1
Pharmacopoeial impurityArtesunate Related Compound CCat. No. P-A192-007CAS 82596-30-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.